La cardiopatia ischemica nel paziente affetto da malattia renale cronica

Luca Di Lullo; Fulvio Floccari; Antonio De Pascalis; Rodolfo Rivera; Antonio Bellasi; Alberto Santoboni; Francesca Santoboni; Annalisa Villani; Moreno Malaguti; Claudio Ronco

doi:10.33393/gcnd.2016.719

Authors

Luca Di Lullo U.O.C. Nefrologia e Dialisi, Ospedale “Parodi-Delfino”, Colleferro (RM)
Fulvio Floccari U.O.C. Nefrologia e Dialisi, Ospedale “S. Paolo”, Civitavecchia (RM)
Antonio De Pascalis U.O.C. Nefrologia e Dialisi, Ospedale “V. Fazzi”, Lecce
Rodolfo Rivera Clinica Nefrologica, Ospedale “S. Gerardo”, Monza
Antonio Bellasi U.O.C. Nefrologia e Dialisi, Ospedale “S. Anna”, Como
Alberto Santoboni U.O.C. Nefrologia e Dialisi, Ospedale “Parodi-Delfino”, Colleferro (RM)
Francesca Santoboni U.O.C. Nefrologia e Dialisi, Ospedale “Parodi-Delfino”, Colleferro (RM)
Annalisa Villani Reparto Nefrologia e Dialisi, Policlinico “L. Di Liegro”, Roma
Moreno Malaguti U.O.C. Nefrologia e Dialisi, Ospedale “S. Paolo”, Civitavecchia (RM)
Claudio Ronco International Renal Research Institute, Ospedale “S. Bortolo”, Vicenza

DOI:

https://doi.org/10.33393/gcnd.2016.719

Keywords:

Atherosclerosis, Chronic kidney disease, Coronary artery disease, Coronary revascularization

Abstract

There is a great deal of data demonstrating a close association between chronic kidney disease (CKD) and cardiovascular disease, particularly coronary artery disease (CAD). About one half of deaths in patients with end-stage renal disease (ESRD) are of cardiovascular causes. The association between CKD and ischemic heart disease can be explained in part because both conditions are related to the traditional risk factors for atherosclerotic vascular disease. However, CKD might also have a casual role in the development and progression of CAD, with several mechanisms potentially involved. Among CAD patients, those with CKD have systematically a worse prognosis than those without CKD irrespective of the clinical presentation or the treatments applied. Current therapy is based on small trials and observational data and on the extrapolation of the strategies that have been proved useful in the general population, although many treatments that have been shown to improve the prognosis of CAD patients are underused in those with renal impairment. (Cardionephrology)